Aitken M L, Sparks R, Anderson K, Albert R K
Am Rev Respir Dis. 1984 Nov;130(5):831-3. doi: 10.1164/arrd.1984.130.5.831.
Drug susceptibility testing is usually performed when Mycobacterium tuberculosis organisms are recovered from Asian immigrants or from patients whose sputum remains culture positive despite several months of antituberculosis medication. Alcoholism, previous antituberculosis treatment, history of adverse reactions to previous treatment, and patient unreliability have also been suggested as risk factors, but the ability of these factors to predict the presence of drug-resistant organisms has not been assessed. Starting in January 1980, the Washington State Tuberculosis Laboratory began testing every positive M. tuberculosis culture for drug resistance. This enabled us to prospectively evaluate the sensitivity and specificity of 7 risk factors for drug resistance in consecutive patients. From January 1, 1980, through December 31, 1982, cultures from 803 patients were positive for M. tuberculosis; 766 of these (95%) were tested for drug resistance. The incidence of resistance was 13% (101/766). Of the 101 patients with drug-resistant organisms, 61 (60%) were Asian, supporting the need to routinely test Asian immigrants for drug-resistant disease. The ability of the other risk factors to separate the 40 non-Asians (40%) with drug-resistant disease from the group of 513 non-Asians with drug-sensitive organisms was poor. All risk factors were insensitive and had a high false positive rate. These results demonstrate that the presence of drug-resistant disease in non-Asians cannot accurately be predicted. This finding suggests that all cultures of M. tuberculosis should be tested for drug sensitivity, and that in areas where the incidence of drug resistance is sufficiently high, initial treatment should be with 3 drugs until drug susceptibility is known.
当从亚洲移民或痰培养尽管经过数月抗结核治疗仍呈阳性的患者中分离出结核分枝杆菌时,通常会进行药敏试验。酗酒、既往抗结核治疗史、既往治疗不良反应史以及患者不可靠等因素也被认为是危险因素,但这些因素预测耐药菌存在的能力尚未得到评估。从1980年1月开始,华盛顿州结核病实验室开始对每例结核分枝杆菌培养阳性样本进行耐药性检测。这使我们能够前瞻性地评估连续患者中7种耐药危险因素的敏感性和特异性。从1980年1月1日至1982年12月31日,803例患者的培养物结核分枝杆菌呈阳性;其中766例(95%)进行了耐药性检测。耐药发生率为13%(101/766)。在101例有耐药菌的患者中,61例(60%)为亚洲人,这支持了对亚洲移民常规检测耐药疾病的必要性。其他危险因素将40例有耐药疾病的非亚洲人(40%)与513例有药敏菌的非亚洲人区分开来的能力较差。所有危险因素均不敏感且假阳性率高。这些结果表明,非亚洲人中耐药疾病的存在无法准确预测。这一发现表明,所有结核分枝杆菌培养物都应进行药敏检测,并且在耐药发生率足够高的地区,初始治疗应使用三种药物,直到药敏结果明确。